miR-564: A potential regulator of vascular smooth muscle cells and therapeutic target for aortic dissection
Min Li(Qingdao University), Tao Yu(Shanghai Jiao Tong University), Xiuxiu Fu(Qingdao University), Yanyan Yang(Wannan Medical College), Jianxun Wang(Qingdao University), Zhibin Wang(Qingdao University), Xiaoxin Li(Huaqiao University), Qianqian Xue(Ministry of Ecology and Environment), Xiangqin He(Nanchang University), Jinbao Zong(Qingdao University), Shaoyan Jiang(Shenzhen Maternity and Child Healthcare Hospital)
Cited by 28
Related Papers
Lactate metabolism in human health and disease
|Signal Transduction and Targeted Therapy|2022|1.4k
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
|SSRN Electronic Journal|2020|963
CRISPR/Cas9 therapeutics: progress and prospects
|Signal Transduction and Targeted Therapy|2023|706
MicroRNA-103/107 Regulate Programmed Necrosis and Myocardial Ischemia/Reperfusion Injury Through Targeting FADD
|Circulation Research|2015|274